Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Bure Equity AB (publ)
  6. Company
    BURE   SE0000195810

BURE EQUITY AB (PUBL)

(BURE)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Business Summary
Logo Bure Equity AB (publ)
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Sales per Business
20192020Delta
Mercuri347.0033%241.0069.7% -30.55%
Investment AB Bure22.002.1%21.006.1% -4.55%
Atle Investment Management13.001.2%4.001.2% -69.23%
SEK in Million
Sales per region
20192020Delta
Europe206.0019.6%153.0044.3% -25.73%
Sweden107.0010.2%73.0021.1% -31.78%
Rest of Nordics38.003.6%21.006.1% -44.74%
Asia25.002.4%13.003.8% -48%
North America6.000.6%7.002% +16.67%
SEK in Million
Managers
Name Title Age Since
Henrik Gustaf Blomquist President & Chief Executive Officer 50 2013
Max Jonson Chief Financial Officer 53 2013
Sophie Ingrid Hagstr÷mer Investment Director 41 2019
Carl Peter Staffan Bj÷rkman Independent Director 51 2010
Bengt Georg Gustaf Engstr÷m Independent Director 68 2014
Anna Charlotta Falvin Independent Director 55 2015
Sarah Eddy McPhee, Dr. Independent Director 67 2016
Carsten Nils Erik Browall Independent Director 63 2019
Oskar H÷rnell Manager-Investment - 2015
Trolle Sahlstrom Manager-Investment 33 2017
Members of the board
Name Title Age Since
Patrik Tigerschiold Chairman 57 2013
Carl Peter Staffan Bj÷rkman Independent Director 51 2010
Bengt Georg Gustaf Engstr÷m Independent Director 68 2014
Anna Charlotta Falvin Independent Director 55 2015
Sarah Eddy McPhee, Dr. Independent Director 67 2016
Carsten Nils Erik Browall Independent Director 63 2019
Shareholders
NameEquities%
Patrik Tigerschiold 7,733,405 10.4%
Bjorkman Family 6,116,012 8.25%
Fjńrde AP-fonden 5,822,629 7.85%
SEB Investment Management AB 4,020,234 5.42%
AMF Fonder AB 3,825,084 5.16%
Ted Tigerschiold 3,746,052 5.05%
Stephanie Tigerschiold 3,712,073 5.01%
Dimensional Fund Advisors LP 1,795,331 2.42%
The Vanguard Group, Inc. 1,479,040 1.99%
Norges Bank Investment Management 1,463,705 1.97%
Holdings
NameEquities%Valuation
VITROLIFE AB (PUBL) (VITR) 20,573,285 15.2% 1,273,472,146 USD
MYCRONIC AB (PUBL) (MYCR) 27,317,163 27.9% 637,112,183 USD
XVIVO PERFUSION AB (PUBL) (XVIVO) 4,367,504 14.8% 134,448,632 USD
ACQ BURE AB (PUBL) (ACQ SPAC) 7,000,000 20.0% 78,225,280 USD
CAVOTEC SA (CCC) 34,071,619 36.4% 75,321,787 USD
OVZON AB (PUBL) (OVZON) 5,861,034 11.4% 40,684,778 USD
MENTICE AB (PUBL) (MNTC) 3,644,059 14.7% 39,715,506 USD
Company contact information
Bure Equity AB
Nybrogatan 6
Stockholm 114 34

Phone : +46.8.614.00.20
Fax : +46.8.614.00.38
Web : http://www.bure.se
Brand Portfolio
In partnership withAllbrands.markets
More brands of Bure Equity AB (publ)